Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

86
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
86
Relative Risk01:12

Relative Risk

128
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
128
Hazard Ratio01:12

Hazard Ratio

96
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
96
Testing a Claim about Population Proportion01:24

Testing a Claim about Population Proportion

3.3K
A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
3.3K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

162
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Competing-triggering effect models for multitype recurrent event data.

Biometrics·2026
Same author

Incorporating Auxiliary Information into Assessment of Accuracy and Discrimination of Risk Models When Some Predictors are Missing.

Statistics in medicine·2026
Same author

A Surrogate-Calibrated Updating Method for Logistic Regression With Missing Covariates.

Statistics in medicine·2026
Same author

Prediction of transition probabilities in multi-state models with nested case-control data.

Biometrics·2025
Same author

Dynamic prediction by landmarking with data from cohort subsampling designs.

Statistical methods in medical research·2025
Same author

Baseline characteristics of participants in the Biomarkers for Evaluating Spine Treatments clinical trial: a sequential multiple assignment randomized trial for chronic low back pain†.

Pain medicine (Malden, Mass.)·2025
Same journal

A Bayesian functional concurrent zero-inflated Dirichlet-multinomial regression model with application to infant microbiome.

Biostatistics (Oxford, England)·2026
Same journal

Towards optimal environmental policies: policy learning under arbitrary bipartite network interference.

Biostatistics (Oxford, England)·2026
Same journal

Multilevel functional quantile principal component analysis.

Biostatistics (Oxford, England)·2026
Same journal

Adaptive transfer learning for time-to-event modeling with applications in disease risk assessment.

Biostatistics (Oxford, England)·2026
Same journal

High-dimensional test for one-sided hypotheses.

Biostatistics (Oxford, England)·2026
Same journal

NBSR: a Negative Binomial Softmax Regression model for microRNA-seq data analysis.

Biostatistics (Oxford, England)·2026
查看所有相关文章

相关实验视频

Updated: Jun 13, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

从嵌套的病例控制研究中汇集控制与比例风险模型.

Yen Chang1, Anastasia Ivanova1, Demetrius Albanes2

  • 1Department of Biostatistics, University of North Carolina, 135 Dauer Drive, Chapel Hill,North Carolina 27599, USA.

Biostatistics (Oxford, England)
|September 10, 2024
PubMed
概括
此摘要是机器生成的。

这项研究通过将Lunn和McNeil的比例危险方法扩展到嵌套的病例控制研究来增强对竞争风险的回归建模. 这种方法在嵌套病例控制分析中为罕见的故障类型提供了显著的效率增长.

关键词:
考克斯的比例危险模型.特定原因的危险 特定原因的危险竞争的风险是竞争的风险.双重编码是可以实现的.嵌套案例 控制研究相对风险模型的比例风险模型.

更多相关视频

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

相关实验视频

Last Updated: Jun 13, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

科学领域:

  • 生物统计学 生物统计学
  • 流行病学 流行病学
  • 生存分析的分析.

背景情况:

  • 对竞争性风险的标准回归使用每个原因的单独模型.
  • 伦和麦克尼尔 (1995) 的方法假设效率和因果交叉比较的因果特异性危险是相称的.
  • 将这种比例危险模型扩展到嵌套的病例控制研究对于复杂的数据至关重要.

研究的目的:

  • 将Lunn和McNeil (1995) 的比例危险模型扩展到嵌套的病例控制研究.
  • 为了适应竞争风险数据中的额外匹配和不相称性.
  • 与全队列分析相比,评估嵌套病例控制分析中的效率增长.

主要方法:

  • 应用扩展的伦和麦克尼尔比例危险模型.
  • 在嵌套案例控制设计中分析潜在的竞争风险数据.
  • 纳入处理不成比例的方法和来自多项研究的数据在一个队列内.

主要成果:

  • 在完整的队列分析中观察到适度的效率增长.
  • 嵌套案例对照分析表明了显著的效率增长,特别是对于罕见的故障类型.
  • 通过广泛的模拟研究和来自前列腺,肺部,结肠直肠和卵巢癌查试验 (PLCO) 的现实世界的数据进行验证.

结论:

  • 扩展的Lunn和McNeil模型提供了一种有效的方法来分析嵌套病例控制研究中的竞争风险.
  • 这种方法对罕见事件特别有益,提高了统计能力.
  • 这些发现支持在涉及复杂生存数据的流行病学研究中使用这种扩展模型.